US2009274715A1PendingUtilityA1
Tick chitinase
Est. expiryFeb 28, 2022(expired)· nominal 20-yr term from priority
Inventors:Kozo FujisakiHideyuki NagasawaIkuo IgarashiHiroshi SuzukiChihiro SugimotoGakunan GenMyonjo YuNaotoshi Tsuji
C12N 9/2442C12Y 302/01014A61P 33/14C07K 16/40A61K 38/00A61P 31/04G01N 2500/00C12Q 1/34
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel chitinase, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the chitinase, and a screening method for screening a substance capable of modifying the chitinase, are disclosed. According to the chitinase, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as piroplasmosis, Q fever, or viral encephalitis.
Claims
exact text as granted — not AI-modified1 . A method for treating or preventing a tick-borne infection, comprising administering to a subject in need thereof a polypeptide selected from the group consisting of:
(1) a polypeptide consisting of the amino acid sequence of SEQ ID NO: 2; (2) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 and exhibiting a chitinase activity; (3) a polypeptide exhibiting a chitinase activity and comprising an amino acid sequence in which one or plural amino acids are substituted, deleted, and/or inserted at one or plural positions in the amino acid sequence of SEQ ID NO: 2; and (4) a polypeptide comprising an amino acid sequence having a 60% or more homology with the amino acid sequence of SEQ ID NO: 2, and exhibiting a chitinase activity,
or a fragment of the polypeptide in an amount effective therefor.
2 . The method according to claim 1 , wherein the fragment of the polypeptide is an immunogenic fragment of the polypeptide.
3 . The method according to claim 1 , wherein the polypeptide is a polypeptide consisting of the amino acid sequence of SEQ ID NO: 2.
4 . The method according to claim 1 , wherein the polypeptide is a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 and exhibiting a chitinase activity.
5 . The method according to claim 1 , wherein the polypeptide is a polypeptide comprising an amino acid sequence having a 70% or more homology with the amino acid sequence of SEQ ID NO: 2, and exhibiting a chitinase activity.
6 . The method according to claim 1 , wherein the polypeptide is a polypeptide comprising an amino acid sequence having a 80% or more homology with the amino acid sequence of SEQ ID NO: 2, and exhibiting a chitinase activity.
7 . The method according to claim 1 , wherein the polypeptide is a polypeptide comprising an amino acid sequence having a 90% or more homology with the amino acid sequence of SEQ ID NO: 2, and exhibiting a chitinase activity.
8 . The method according to claim 1 , wherein the polypeptide is a polypeptide comprising an amino acid sequence having a 95% or more homology with the amino acid sequence of SEQ ID NO: 2, and exhibiting a chitinase activity.Join the waitlist — get patent alerts
Track US2009274715A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.